Skip to content
Clinical Trials – home
PortugalBack to Portugal

Clinical trials in Aveiro – page 4

46 clinical trials in Aveiro, Portugal across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

PortugalOur site in PortugalEnsaios-Clinicos.pt(opens in a new tab)
Aveiro at a glance
46
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

46 trials in Aveiro

Open in trial search

Study on Itepekimab for Former Smokers with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Myelofibrosis+1

Not recruiting

Study of Navtemadlin for Patients with Myelofibrosis Resistant to JAK Inhibitors

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Danazol
  • Sponsor:Kartos Therapeutics Inc.

Study on Preventing Infections After Abdominal Surgery Using D-PLEX with Doxycycline Hyclate for Patients Undergoing Abdominal Surgery

InvestigationalNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Doxycycline Hyclate
  • Sponsor:Polypid Ltd.

Study on Aficamten for Adults with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Aficamten
  • Sponsor:Cytokinetics Inc.

Study on Long-Term Safety of Itepekimab for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Rheumatoid arthritis

Not recruiting

Study on the Effects of Folate-Based Liposomes with Methotrexate for Patients with Moderate-to-Severe Rheumatoid Arthritis

InvestigationalNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Methotrexate
  • Sponsor:Solfarcos Solucoes Farmaceuticas E Cosmeticas Lda.

Study Comparing Crovalimab and Eculizumab for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently on Complement Inhibitors

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Crovalimab
  • Sponsor:F. Hoffmann-La Roche AG

Study on the Effectiveness and Safety of Crovalimab vs. Eculizumab for Adults and Adolescents with Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Treated with Complement Inhibitors

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Crovalimab
  • Sponsor:F. Hoffmann-La Roche AG

HIV infection

Not recruiting

Study Comparing Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV Treatment in Adults New to Antiretroviral Therapy

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Bictegravir
  • Sponsor:Viiv Healthcare UK Limited

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen Cilag International

Other cities in Portugal

The busiest research cities in the country

All 48 cities in Portugal

Clinical research in Aveiro

What the registry says about research in the country

01 Cardiovascular Research

Innovative clinical trials focusing on cardiovascular conditions, including studies of new treatments for acute myocardial infarction and hypertrophic cardiomyopathy. Researchers are evaluating novel therapies for stroke prevention and heart-related complications.

  • Hypertrophic Cardiomyopathy Treatment
  • Stroke Prevention Therapies
  • Acute Myocardial Infarction Management

Advanced studies targeting improved outcomes in patients with various cardiac conditions through innovative therapeutic approaches.

02 Respiratory Medicine

Research initiatives addressing chronic respiratory conditions, with particular emphasis on chronic rhinosinusitis and COPD. Studies are evaluating new therapeutic agents for managing symptoms and improving patient quality of life.

  • Chronic Rhinosinusitis Treatment
  • COPD Management
  • Nasal Polyps Therapy

Comprehensive trials exploring both symptomatic relief and long-term disease modification strategies.

03 Metabolic Disorders

Clinical investigations into metabolic conditions, focusing on obesity, diabetes, and related complications. Studies are examining new treatments for hypertriglyceridemia and innovative approaches to weight management.

  • Obesity Treatment
  • Diabetic Complications
  • Lipid Management

Groundbreaking research aimed at developing effective therapies for metabolic disorders and their associated complications.

04 Hematology Research

Studies investigating treatments for blood disorders, particularly focusing on conditions like Paroxysmal Nocturnal Hemoglobinuria and various forms of neutropenia. Researchers are evaluating novel therapeutic approaches.

  • PNH Treatment Development
  • Neutropenia Management
  • Blood Disorder Therapies

Innovative clinical trials exploring new treatment options for rare and chronic blood conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.